Thyroid Storm (4 Ps)
Burch-Wartofsky ≥ 45; sequence: 1. Propranolol, 2. PTU, 3. Potassium Iodide (1 hr AFTER PTU!), 4. Prednisone/Hydrocortisone.
Myxedema Coma
Hypothermia, bradycardia, hypoventilation, hyponatremia, stupor; treat with IV Levothyroxine (± T3) + empiric IV Hydrocortisone.
Graves vs. Subacute RAIU
Graves: diffuse high RAIU (TSI antibodies, ophthalmopathy). Subacute/Factitious: low/absent RAIU.
Thyroid Nodule Workup
First steps: Serum TSH + Thyroid Ultrasound. Low TSH → RAIU scan (hot = benign). Normal/High TSH → FNA biopsy.
Thyroid Cancer Hallmarks
Papillary: Orphan Annie eyes, psammoma bodies. Medullary: Calcitonin/amyloid, RET mutation (MEN 2A/2B).
Primary vs. Secondary AI
Primary (Addison): High ACTH, hyperpigmentation, hyperkalemia, low aldosterone. Secondary: Low ACTH, normal K+/aldosterone.
Pheochromocytoma Rule
Episodic Headaches, Sweating, Tachycardia; diagnose with plasma/urine metanephrines; Alpha-blockade (Phenoxybenzamine) BEFORE Beta-blockade!
Endocrine Viscerosomatics
Thyroid sympathetics: T1–T4 (cervical ganglia); Adrenal sympathetics: T10–T11 (lesser splanchnic).
Thyroid Storm vs. Myxedema Coma: Pathophysiology & Presentation
Thyroid emergencies represent life-threatening decompensations of hyperthyroidism or hypothyroidism triggered by acute physiological stressors (infection, trauma, noncompliance, surgery).
| Feature | Thyroid Storm | Myxedema Coma |
|---|---|---|
| Body Temperature | Hyperthermia (often > 104°F / 40°C) | Severe hypothermia (< 95°F / 35°C) |
| Cardiovascular | Sinus tachycardia, atrial fibrillation, high-output failure | Sinus bradycardia, hypotension, pericardial effusion |
| Neuropsychiatric | Extreme agitation, psychosis, delirium, seizures | Lethargy, stupor, coma ('myxedema madness') |
| Precipitating Factors | Infection, iodinated contrast, surgery, DKA | Cold exposure, sedatives, infection, stroke |
Interactive 2K Master Atlas Plate
Hemodynamic & Metabolic Contrast: Thyroid Storm vs. Myxedema Coma
Thyroid Storm is a life-threatening hypermetabolic crisis precipitated by acute infection, surgery, trauma, DKA, amiodarone/iodinated contrast load (Jod-Basedow), or abrupt thionamide discontinuation in a patient with underlying Graves disease or toxic multinodular goiter. Excess T3 upregulates cardiac beta-1 adrenergic receptor density, myosin heavy-chain alpha expression, and ubiquitous Na+/K+-ATPase thermogenesis while lowering systemic vascular resistance—producing hyperpyrexia (>40 C / 104 F), high-output heart failure, atrial fibrillation with rapid ventricular response, wide pulse pressure, severe agitation/delirium, diarrhea, and jaundice. Conversely, Myxedema Coma occurs in longstanding untreated hypothyroidism precipitated by cold exposure, infection, myocardial infarction, or sedative/opioid drugs, presenting with the cardinal triad of severe hypothermia (<35 C), stupor/coma, and hypoventilation with hypercapnic respiratory acidosis, accompanied by sinus bradycardia, pericardial/pleural effusions, non-pitting glycosaminoglycan myxedema, and euvolemic hyponatremia (from impaired free-water clearance and elevated ADH).
Why Hydrocortisone Precedes Levothyroxine in Myxedema Coma Resuscitation
In the emergency management of Myxedema Coma, the single highest-yield board rule governs the order of hormone administration: always administer stress-dose intravenous Hydrocortisone (100 mg IV every 8 hours) PRIOR to or simultaneously with intravenous Levothyroxine (T4) and Liothyronine (T3). First, autoimmune hypothyroidism (Hashimoto thyroiditis) frequently coexists with autoimmune primary adrenal insufficiency (Addison disease) as part of Autoimmune Polyglandular Syndrome Type 2 (Schmidt syndrome), or pituitary disease may cause central hypothyroidism alongside secondary adrenal insufficiency. Second, severe hypothyroidism slows hepatic metabolic clearance of cortisol; abruptly restoring thyroid hormone accelerates metabolic rate and hepatic cortisol degradation, which will precipitate fatal acute adrenal crisis and cardiovascular collapse if exogenous glucocorticoid coverage is not already on board.
The Stepwise 4-P Protocol for Thyroid Storm
Treatment must be initiated immediately upon clinical suspicion without waiting for laboratory confirmation:
- Propranolol (Beta-Blocker): High-dose IV/oral propranolol controls adrenergic symptoms and uniquely blocks peripheral conversion of T4 to T3.
- PTU (Propylthiouracil): Preferred over methimazole in storm because it blocks de novo thyroid hormone synthesis and peripheral T4 to T3 conversion.
- Potassium Iodide (Lugol solution or SSKI): Administer at least 1 hour after PTU to prevent the Wolff-Chaikoff effect from becoming substrate for new hormone synthesis (Jod-Basedow phenomenon).
- Prednisone / Hydrocortisone (Steroids): IV hydrocortisone treats potential relative adrenal insufficiency and inhibits peripheral T4 to T3 conversion.
| Execution Order | Therapeutic Agent | Mechanism of Action | Critical Sequencing Rule |
|---|---|---|---|
| Step 1: Beta-Blockade | Propranolol (60-80 mg PO q4h or IV) or Esmolol infusion | Controls life-threatening adrenergic tachyarrhythmias + inhibits peripheral 5'-deiodinase conversion of T4 to T3 | Use cardioselective esmolol or diltiazem if patient has severe reactive asthma; avoid in decompensated high-output heart failure with low EF |
| Step 2: Thionamide (Block Synthesis) | Propylthiouracil (PTU 200 mg q4h) preferred in acute storm over Methimazole | Inhibits Thyroid Peroxidase (TPO) organification/coupling + PTU additionally blocks peripheral T4 -> T3 conversion | PTU is preferred in Thyroid Storm and 1st Trimester of pregnancy; transition to Methimazole after storm/1st trimester due to PTU hepatotoxicity |
| Step 3: Iodine Solution (Block Release) | Potassium Iodide (SSKI) or Lugol Solution | Acute Wolff-Chaikoff effect: inhibits proteolysis of thyroglobulin and release of preformed T4/T3 from follicles | MUST wait at least 1 HOUR after giving PTU/Methimazole before giving iodine! Giving iodine first fuels new hormone synthesis (Jod-Basedow phenomenon) |
| Step 4: Glucocorticoid + Cooling | Hydrocortisone (100 mg IV q8h) or Dexamethasone + Cooling blankets / Acetaminophen | Blocks peripheral T4 -> T3 conversion AND treats coexisting relative adrenal insufficiency from accelerated cortisol clearance | NEVER use aspirin (salicylates) for fever in thyroid storm! Salicylates displace T4/T3 from Thyroid-Binding Globulin (TBG), worsening free hormone toxicity |
The Mandatory 1-Hour PTU-to-Iodine Rule (Wolff-Chaikoff vs. Jod-Basedow)
Treating Thyroid Storm requires executing the 4-P protocol in strict physiological sequence: (1) Propranolol (blocks beta-1/beta-2 receptors AND inhibits peripheral 5'-deiodinase conversion of T4 to active T3), (2) Propylthiouracil (PTU) (inhibits thyroid peroxidase [TPO] synthesis of new hormone AND blocks peripheral T4 -> T3 conversion), (3) Potassium Iodide (SSKI or Lugol solution) administered at least 1 HOUR AFTER PTU, and (4) Prednisolone / Hydrocortisone (inhibits T4 -> T3 conversion and prevents relative adrenal crisis). Administering Lugol iodine before TPO is blocked by PTU provides raw iodide substrate to the hyperactive thyroid gland, fueling massive synthesis of new thyroid hormone (Jod-Basedow phenomenon) and fatally worsening the storm; waiting >=1 hour allows PTU to halt organification so that iodine induces only the acute Wolff-Chaikoff effect (blocking proteolytic release of preformed hormone).
Thionamide Adverse Effects (Agranulocytosis, Hepatotoxicity & Aplasia Cutis)
Both propylthiouracil (PTU) and methimazole carry a serious 0.3% risk of idiosyncratic agranulocytosis (absolute neutrophil count <500/mm3), typically occurring within the first 90 days of therapy: any patient on a thionamide who develops acute fever, sore throat (pharyngitis), or oral ulcers must immediately discontinue the drug and obtain a stat CBC with differential (routine periodic WBC screening in asymptomatic patients is not useful because agranulocytosis develops abruptly). Furthermore, PTU carries an FDA Black Box Warning for severe fulminant hepatic necrosis, whereas methimazole causes cholestatic jaundice and is teratogenic during first-trimester organogenesis—causing aplasia cutis congenita (congenital absence of scalp skin), choanal atresia, and esophageal atresia. Consequently, PTU is used during the 1st trimester of pregnancy (and in acute thyroid storm), and patients are switched to methimazole for the 2nd and 3rd trimesters and all non-pregnant outpatient therapy.
Acute Adrenal Insufficiency & Adrenal Crisis
Adrenal crisis occurs when cortisol production fails to meet metabolic demand. Primary adrenal insufficiency (Addison disease) presents with hyperkalemia, hyponatremia, and hyperpigmentation (elevated ACTH/MSH). Secondary/tertiary adrenal insufficiency (abrupt steroid withdrawal) exhibits normal potassium (aldosterone preserved by RAAS).
Diagnostic workup: Serum cortisol and ACTH, followed by high-dose Cosyntropin (synthetic ACTH) stimulation test. In an unstable patient, do not delay treatment: administer IV hydrocortisone 100 mg stat; dexamethasone may be used if testing must be preserved as it does not cross-react in the cortisol assay.
| Adrenal Insufficiency Type | Etiology & Pathophysiology | ACTH, Aldosterone & Electrolyte Profile | Acute Crisis & Chronic Replacement Protocol |
|---|---|---|---|
| Primary (Addison Disease) | Autoimmune adrenalitis (21-hydroxylase Abs, #1 in West), TB (#1 worldwide), Waterhouse-Friderichsen (meningococcemia), bilateral adrenal hemorrhage/metastasis | HIGH ACTH (hyperpigmentation via POMC/alpha-MSH), LOW cortisol, LOW aldosterone -> hyponatremia, HYPERKALEMIA, NAGMA | Acute Crisis: immediate 0.9% NaCl + D5W + IV Hydrocortisone (100 mg bolus, then 200 mg/24h) or Dexamethasone (if cosyntropin test pending). Chronic: Hydrocortisone + Fludrocortisone |
| Secondary / Tertiary | Abrupt cessation of chronic exogenous glucocorticoids (>3 weeks use, #1 overall cause), pituitary adenoma/apoplexy, Sheehan syndrome | LOW ACTH (no hyperpigmentation), LOW cortisol, NORMAL aldosterone (preserved RAAS) -> euvolemic hyponatremia, NORMAL K+, no severe volume collapse | Acute: IV Hydrocortisone + isotonic fluids. Chronic: glucocorticoid replacement (Hydrocortisone/Prednisone) ONLY; fludrocortisone is NOT needed |
Interactive 2K Master Atlas Plate
Differentiating Primary (Addison) vs. Secondary/Tertiary Adrenal Insufficiency
Three clinical and biochemical features immediately distinguish Primary Adrenal Insufficiency (Addison disease—destruction of all three adrenal cortical zones: glomerulosa, fasciculata, and reticularis) from Secondary/Tertiary Adrenal Insufficiency (pituitary ACTH deficiency or hypothalamic CRH suppression from chronic exogenous glucocorticoid use): (1) Cutaneous & Mucosal Hyperpigmentation is present ONLY in Primary Adrenal Insufficiency because loss of cortisol negative feedback drives massive pituitary transcription of pro-opiomelanocortin (POMC), which is cleaved into both ACTH and alpha-melanocyte-stimulating hormone (alpha-MSH), darkening palmar creases, buccal mucosa, and scars. (2) Hyperkalemia and Severe Volume Depletion occur ONLY in Primary Adrenal Insufficiency because the zona glomerulosa (which synthesizes aldosterone) is regulated primarily by the renin-angiotensin II system and serum K+, NOT by pituitary ACTH; in secondary/tertiary insufficiency, aldosterone secretion remains intact, so serum K+ is normal. (3) Hyponatremia occurs in both primary and secondary insufficiency because cortisol is required to tonically suppress hypothalamic ADH (vasopressin) secretion.
Cosyntropin (ACTH) Stimulation Test & Emergency Dexamethasone vs. Hydrocortisone Selection
In a hemodynamically unstable patient presenting in Acute Adrenal Crisis (refractory hypotension/shock, abdominal pain, vomiting, fever, hyponatremia, hypoglycemia, hyperkalemia, and eosinophilia), never delay treatment to perform diagnostic testing: immediately infuse rapid intravenous 0.9% Normal Saline with Dextrose (D5NS) and administer stress-dose intravenous glucocorticoids. If the diagnosis of adrenal insufficiency has already been established, give IV Hydrocortisone 100 mg bolus (which provides both glucocorticoid and sufficient mineralocorticoid activity at stress doses); if the diagnosis is unconfirmed and an ACTH (Cosyntropin) Stimulation Test needs to be performed concurrently, administer IV Dexamethasone (4 mg) instead, because dexamethasone does not cross-react with the serum cortisol immunoassay. On the standard 250-mcg Cosyntropin test, failure of 30-to-60-minute serum cortisol to rise to >=18–20 mcg/dL confirms adrenal insufficiency.
Hyperthyroidism & Thyrotoxicosis Etiologies and RAIU Scan Patterns
Thyrotoxicosis denotes the clinical syndrome of excess circulating free triiodothyronine (T3) and thyroxine (T4), regardless of source, whereas hyperthyroidism specifically indicates excessive de novo synthesis and secretion by the thyroid gland. Primary hyperthyroidism suppresses pituitary TSH (< 0.01 mIU/L) via negative feedback while elevating free T4 and/or free T3. Differentiating the underlying etiology relies on clinical stigmata, thyroid-stimulating immunoglobulin (TSI) serology, and the 24-hour Radioactive Iodine Uptake (RAIU) scintigraphy scan, which distinguishes high-uptake states of active follicular synthesis from low-uptake states of destructive thyroiditis or extrathyroidal hormone sources.
| Condition | Pathophysiological Mechanism | Clinical Hallmarks & Exam | RAIU Scan & Thyroglobulin | Definitive Treatment |
|---|---|---|---|---|
| Graves Disease | Type II hypersensitivity: IgG Thyroid-Stimulating Immunoglobulins (TSI) bind and constitutively activate TSH receptors | Diffuse painless goiter with bruit; exophthalmos/ophthalmopathy (retro-orbital glycosaminoglycan deposition) & pretibial myxedema | Diffusely increased RAIU (> 35–80%); elevated serum thyroglobulin | Methimazole (PTU in 1st trimester pregnancy), radioactive iodine (131I) ablation (avoid in severe ophthalmopathy/pregnancy), or thyroidectomy |
| Toxic Multinodular Goiter (Plummer Disease) | Polyclonal somatic activating mutations of the TSH receptor in multiple autonomous follicular nodules (older adults) | Irregular nodular goiter, atrial fibrillation, high-output heart failure; NO ophthalmopathy or dermopathy | Patchy, heterogeneous high uptake with multiple 'hot' nodules and suppressed surrounding tissue | Radioactive iodine (131I) ablation or subtotal/total thyroidectomy after beta-blocker/methimazole stabilization |
| Toxic Adenoma | Monoclonal somatic gain-of-function mutation in TSH receptor or Gsα subunit within a single follicular adenoma | Solitary palpable thyroid nodule with hyperthyroid symptoms | Single focal 'hot' nodule with complete suppression of the remaining gland | Radioactive iodine ablation or surgical lobectomy |
| Subacute Granulomatous Thyroiditis (de Quervain) | Post-viral granulomatous follicular destruction (often post-URI: Coxsackie, mumps, adenovirus) releasing preformed colloid | Exquisitely tender, painful thyroid radiating to jaw/ears, fever, markedly elevated ESR/CRP; triphasic course | Diffusely LOW / absent RAIU (< 5%); elevated serum thyroglobulin | Self-limiting: NSAIDs (aspirin/ibuprofen) first-line; oral corticosteroids (prednisone) for severe refractory pain; beta-blockers for symptoms |
| Subacute Lymphocytic (Painless / Postpartum) | Autoimmune lymphocytic destruction variant of Hashimoto occurring within 1 year postpartum; anti-TPO positive | Painless non-tender goiter; transient thyrotoxic phase (2–6 wks) followed by hypothyroid phase | Diffusely LOW RAIU (< 5%); elevated thyroglobulin | Beta-blockers during thyrotoxic phase; levothyroxine if hypothyroid phase is symptomatic (antithyroid drugs are ineffective!) |
| Factitious Thyrotoxicosis | Surreptitious ingestion of exogenous levothyroxine (T4) or liothyronine (T3) for weight loss or psychiatric gain | Hyperthyroid symptoms with atrophic/impalpable thyroid gland (TSH suppression causes gland atrophy) | Diffusely LOW RAIU in thyroid AND undetectable / LOW serum thyroglobulin | Discontinue exogenous hormone; psychiatric evaluation (contrast with Struma Ovarii: pelvic uptake on whole-body RAIU + high thyroglobulin) |
Graves Ophthalmopathy Pathogenesis & Radioiodine Caution
Graves ophthalmopathy (proptosis, lid lag, diplopia from extraocular muscle fibrosis, periorbital edema) is driven by T-cell cytokines (IFN-γ, TNF-α, IL-1) and TSI activation of orbital fibroblasts expressing TSH and IGF-1 receptors, which secrete hydrophilic glycosaminoglycans (hyaluronic acid) and differentiate into mature adipocytes. Because ophthalmopathy is an independent autoimmune process, it can worsen even after thyroid ablation. Radioactive iodine (131I) therapy can acutely exacerbate Graves ophthalmopathy by releasing thyroid antigens; patients with mild-to-moderate eye disease undergoing 131I require concurrent oral prednisone prophylaxis (or teprotumumab, an IGF-1R monoclonal antibody, for severe disease).
Amiodarone-Induced Thyrotoxicosis (Type 1 vs. Type 2) & Wolff-Chaikoff vs. Jod-Basedow
Amiodarone is 37% iodine by weight and structurally resembles T4. It causes three distinct thyroid phenomena: (1) Hypothyroidism via the Wolff-Chaikoff effect (autoregulatory inhibition of thyroid peroxidase organification by high intrathyroidal iodide load); (2) Type 1 Amiodarone-Induced Thyrotoxicosis (Jod-Basedow phenomenon), where excess iodine triggers autonomous hormone synthesis in patients with latent Graves or multinodular goiter (high vascularity on color Doppler; treated with Methimazole); and (3) Type 2 Amiodarone-Induced Thyrotoxicosis, a direct cytotoxic destructive thyroiditis in normal glands (absent vascularity on Doppler; treated with oral corticosteroids [Prednisone]).
Thionamide Pharmacology: Methimazole vs. Propylthiouracil (PTU)
Both Methimazole and PTU inhibit thyroid peroxidase (TPO), blocking iodide oxidation, organification of tyrosine residues on thyroglobulin, and coupling of MIT/DIT. However, PTU uniquely inhibits peripheral 5'-deiodinase, blocking extrathyroidal conversion of T4 to the more potent T3. Because PTU carries an FDA black-box warning for severe fulminant hepatotoxicity, Methimazole is the drug of choice for all non-pregnant patients and during the 2nd/3rd trimesters of pregnancy. PTU is reserved exclusively for Thyroid Storm and the first trimester of pregnancy (to avoid methimazole teratogenicity: aplasia cutis).
Hypothyroidism Etiologies, Hashimoto Histopathology & Euthyroid Sick Syndrome
Hypothyroidism results from insufficient thyroid hormone production or action, manifesting clinically with generalized metabolic deceleration: cold intolerance, weight gain despite decreased appetite, constipation, bradycardia, diastolic hypertension (from increased systemic vascular resistance), delayed relaxation phase of deep tendon reflexes (Woltman sign), periorbital non-pitting myxedema, carpal tunnel syndrome, hypercholesterolemia, hyponatremia, and menorrhagia. In primary hypothyroidism, serum TSH is elevated and free T4 is low; in subclinical hypothyroidism, TSH is elevated with a normal free T4 (treat with levothyroxine if TSH > 10 mIU/L, pregnant, or symptomatic with positive anti-TPO antibodies). In central (secondary/tertiary) hypothyroidism from pituitary/hypothalamic disease, free T4 is low while TSH is low or inappropriately normal.
| Thyroid Disorder | Pathogenesis & Autoantibodies | TSH, Free T4 & Free T3 Profile | Histopathology & Management |
|---|---|---|---|
| Hashimoto Thyroiditis | Autoimmune CD8+ T-cell destruction + Anti-TPO (>90%) and Anti-Thyroglobulin antibodies; HLA-DR3/DR5 | High TSH, Low Free T4 (early 'Hashitoxicosis' follicular rupture transiently shows Low TSH, High Free T4, and Decreased RAIU) | Dense lymphocytic infiltrate with germinal centers and Hurthle cells (eosinophilic oxyphilic metaplasia); increases risk of Primary Thyroid Marginal Zone B-Cell (MALT) Lymphoma; treat with Levothyroxine |
| Subacute Granulomatous (de Quervain) Thyroiditis | Post-viral (Coxsackie, adenovirus, mumps) granulomatous follicular inflammation | Triphasic: Hyperthyroid (Low TSH, High T4, Very Low RAIU) -> Hypothyroid -> Euthyroid; markedly elevated ESR and CRP | EXQUISITELY TENDER anterior neck pain radiating to jaw/ears with multinucleated giant cells surrounding colloid; treat with NSAIDs (aspirin/ibuprofen) or glucocorticoids if severe |
| Riedel Fibrosing Thyroiditis | IgG4-related systemic sclerosing fibroinflammatory process extending beyond thyroid capsule into strap muscles/trachea/RLN | Normal or High TSH (hypothyroidism in ~30-40%) | ROCK-HARD, fixed, PAINLESS ('woody') goiter mimicking anaplastic thyroid carcinoma (biopsy shows dense keloid-like fibrosis without malignant cells); treat with glucocorticoids, tamoxifen, or decompression |
| Euthyroid Sick Syndrome (Nonthyroidal Illness) | Critical illness/starvation cytokines (IL-6, TNF-alpha) and endogenous cortisol inhibit peripheral 5'-deiodinase (Type 1) and increase Type 3 deiodinase | Mild/moderate: Low Free T3, Elevated Reverse T3 (rT3), Normal TSH & Free T4. Severe prolonged ICU illness: Low T3, Low T4, Low/Normal TSH | Adaptive energy-conservation response in ICU patients; do NOT administer levothyroxine or liothyronine—treat the underlying critical illness and repeat TFTs 4-6 weeks after discharge |
Hashimoto (Chronic Autoimmune) Thyroiditis & MALT Lymphoma Risk
Hashimoto thyroiditis is the most common cause of hypothyroidism in iodine-sufficient regions (whereas iodine deficiency remains #1 worldwide) and is strongly associated with HLA-DR3 and HLA-DR5. CD8+ cytotoxic T-cell-mediated apoptosis and anti-thyroid peroxidase (anti-TPO, > 90%) and anti-thyroglobulin antibodies destroy thyroid follicles. Early follicular rupture can cause transient hyperthyroidism ('Hashitoxicosis') before progressing to chronic hypothyroidism. Histology reveals dense lymphoid aggregates with germinal centers and Hürthle (Askanazy) cells (large oxyphilic follicular cells with abundant granular eosinophilic cytoplasm due to mitochondrial proliferation). Patients carry a 60-fold increased risk of primary thyroid marginal zone B-cell (MALT) lymphoma, presenting as a rapidly enlarging firm neck mass.
Riedel Fibrosing Thyroiditis & Congenital Hypothyroidism (Cretinism)
Riedel thyroiditis is a rare IgG4-related systemic sclerosing disease where dense keloid-like fibrous tissue replaces the thyroid and invades adjacent strap muscles, trachea, and recurrent laryngeal nerves. It presents as a rock-hard, fixed, painless 'woody' goiter that clinically mimics anaplastic thyroid carcinoma. Congenital hypothyroidism (cretinism) results most commonly from thyroid dysgenesis (agenesis/ectopic lingual thyroid, 85%), dyshormonogenesis, or transplacental maternal antibodies. Because maternal T4 crosses the placenta slightly, neonates appear normal at birth but rapidly develop 6 Ps if untreated: Pot-bellied, Pale, Puffy-faced, Protruding umbilicus (umbilical hernia), Protuberant tongue (macroglossia), and Poor brain development (irreversible intellectual disability). Mandatory newborn heel-stick screening (high TSH, low T4) allows immediate levothyroxine initiation.
Euthyroid Sick Syndrome (Nonthyroidal Illness Syndrome)
Hospitalized ICU patients with severe systemic illness (sepsis, trauma, myocardial infarction, cirrhosis, starvation, DKA) frequently exhibit abnormal thyroid function tests without intrinsic thyroid disease—termed Euthyroid Sick Syndrome. Pro-inflammatory cytokines and endogenous cortisol acutely inhibit peripheral 5'-deiodinase, blocking conversion of T4 to active T3 and shunting T4 toward inactive reverse T3 (rT3). Early mild illness shows isolated low T3 with normal T4 and normal TSH; prolonged critical illness suppresses central TRH/TSH pulsatility, causing low T3, low T4, and low-normal TSH. Thyroid hormone replacement is NOT indicated and may worsen mortality; recheck thyroid labs 4–6 weeks after clinical recovery.
Thyroid Nodule Evaluation Algorithm & The 4 Thyroid Carcinomas
Every palpable or incidental thyroid nodule requires a strict, two-pronged initial workup: (1) Serum TSH and (2) Diagnostic Neck/Thyroid Ultrasonography. Never proceed directly to biopsy without checking TSH first! If TSH is suppressed (low), the next step is a Radioactive Iodine Uptake (RAIU) scan: a hyperfunctioning ('hot') nodule has < 1% risk of malignancy, requires NO Fine-Needle Aspiration (FNA), and is treated for hyperthyroidism; a hypofunctioning ('cold') nodule requires FNA. Conversely, if TSH is normal or elevated, do NOT order an RAIU scan; proceed directly to ultrasound-guided FNA biopsy if the nodule meets size/sonographic risk criteria (≥ 1.0 cm with high-suspicion features: microcalcifications, hypoechogenicity, irregular margins, taller-than-wide shape, or extrathyroidal extension).
| Carcinoma Type | Origin & Epidemiology | Genetic Mutations & Risk Factors | Histopathologic Hallmarks | Metastatic Pattern & Management |
|---|---|---|---|---|
| Papillary Thyroid Carcinoma (PTC) | Follicular cell origin; most common (80–85%); best prognosis (> 95% 10-yr survival) | BRAF V600E, RET/PTC rearrangements; childhood head/neck ionizing radiation | 'Orphan Annie eye' empty ground-glass nuclei, nuclear grooves, intranuclear pseudoinclusions, psammoma bodies | Lymphatic spread to cervical nodes; lobectomy/total thyroidectomy + TSH suppression + 131I ablation; monitor serum thyroglobulin |
| Follicular Thyroid Carcinoma (FTC) | Follicular cell origin; 10–12% of cases; good prognosis | RAS mutations, PAX8-PPARγ translocation; iodine deficiency regions | Uniform follicles; FNA cannot distinguish follicular adenoma from carcinoma—requires surgical histology showing capsular or vascular invasion! | Hematogenous spread to bone and lungs (spares lymph nodes); surgical lobectomy/thyroidectomy + 131I ablation |
| Medullary Thyroid Carcinoma (MTC) | Parafollicular C-cell (neural crest neuroendocrine) origin; 3–5% of cases | RET proto-oncogene germline mutation in MEN 2A and MEN 2B (25%) or sporadic (75%) | Sheets of polygonal/spindle cells in an amyloid stroma (Congo red apple-green birefringence) derived from calcitonin | Rule out pheochromocytoma FIRST; total thyroidectomy; tumor marker is serum Calcitonin and CEA (131I does NOT work on C-cells!) |
| Anaplastic (Undifferentiated) Carcinoma | Dedifferentiated follicular origin in elderly (> 65 yrs); 1–2%; 100% fatal (median survival < 6 months) | TP53 and TERT promoter mutations arising from preexisting papillary/follicular cancer | Pleomorphic giant osteoclast-like multinucleated cells, spindle cells, extensive necrosis, high mitotic rate | Rapidly invading rock-hard mass causing dysphagia, hoarseness (RLN palsy), and stridor; emergent tracheostomy/airway stabilization |
| Hürthle Cell Carcinoma | Oncocytic variant of follicular neoplasia (3%) | Mitochondrial DNA complex I mutations | Sheets of large eosinophilic oxyphilic Hürthle cells with capsular/vascular invasion | Poorly avid for radioactive iodine compared to standard FTC; surgical resection is mainstay |
Why FNA Cannot Diagnose Follicular Thyroid Carcinoma
A classic board examination trap involves a patient whose thyroid FNA cytology returns as 'Follicular Neoplasm (Bethesda Category IV).' Because both benign follicular adenomas and malignant follicular carcinomas consist of identical microfollicular epithelial cells on cytologic aspirate, FNA cannot distinguish between them. Definitive diagnosis of Follicular Thyroid Carcinoma requires diagnostic surgical lobectomy to examine the entire tumor capsule histologically for transcapsular penetration or vascular invasion.
Post-Thyroidectomy Complications: Recurrent Laryngeal Nerve & Hypocalcemia
Total thyroidectomy carries two major anatomical risks: (1) Inadvertent parathyroidectomy or devascularization of the 4 parathyroid glands, causing acute postoperative hypocalcemia within 24–48 hours (perioral numbness, tingling, Chvostek/Trousseau signs, laryngospasm, QT prolongation; treat with IV calcium gluconate and calcitriol); and (2) Recurrent laryngeal nerve (RLN) injury (runs in the tracheoesophageal groove alongside the inferior thyroid artery). Unilateral RLN injury causes a hoarse, breathy voice with the vocal cord paralyzed in a paramedian position; bilateral RLN injury causes acute vocal cord adduction, aphonia, and life-threatening inspiratory stridor requiring emergent intubation or tracheostomy. Injury to the external branch of the superior laryngeal nerve (accompanies superior thyroid artery) paralyzes the cricothyroid muscle, causing voice fatigue and loss of high-pitch projection.
Post-Operative Cancer Surveillance: Thyroglobulin vs. Calcitonin
Following total thyroidectomy and radioactive iodine (131I) remnant ablation for well-differentiated Papillary or Follicular thyroid cancer, patients receive supraphysiologic levothyroxine to suppress TSH (preventing TSH-stimulated tumor growth) and are monitored with serial serum Thyroglobulin (Tg) levels (which should be undetectable, < 0.2 ng/mL, in the absence of anti-Tg antibodies). Any rise in serum thyroglobulin signifies tumor recurrence or metastasis. In contrast, Medullary Thyroid Carcinoma arises from parafollicular C-cells that neither concentrate iodine nor synthesize thyroglobulin; MTC surveillance relies strictly on serum Calcitonin and carcinoembryonic antigen (CEA).
Primary vs. Secondary Adrenal Insufficiency, Waterhouse-Friderichsen & Pheochromocytoma
Adrenal insufficiency (AI) is classified by the anatomical level of hypothalamic-pituitary-adrenal (HPA) axis failure. Primary adrenal insufficiency (Addison disease) results from direct destruction of the adrenal cortex (> 90% loss required), most commonly from autoimmune adrenalitis (anti-21-hydroxylase antibodies) in developed nations (often part of Autoimmune Polyglandular Syndrome Type 1 [AIRE mutation: candidiasis, hypoparathyroidism, Addison] or Type 2 [Schmidt syndrome: Addison + Hashimoto/Graves + Type 1 DM]) and disseminated tuberculosis worldwide. Because all three cortical zones (glomerulosa, fasciculata, reticularis) are destroyed, primary AI causes deficiency of both cortisol AND aldosterone. Conversely, secondary AI (pituitary ACTH deficiency) and tertiary AI (hypothalamic CRH suppression, most commonly from abrupt cessation of chronic exogenous glucocorticoid therapy ≥ 3 weeks) spare aldosterone secretion because the zona glomerulosa remains responsive to the renin-angiotensin-aldosterone system (RAAS).
| Parameter | Primary Adrenal Insufficiency (Addison Disease) | Secondary / Tertiary Adrenal Insufficiency | Waterhouse-Friderichsen Syndrome | Pheochromocytoma / Paraganglioma |
|---|---|---|---|---|
| Primary Etiology | Autoimmune adrenalitis (anti-21-hydroxylase, #1 in US), TB (#1 worldwide), metastatic lung/breast cancer, adrenal hemorrhage | Abrupt withdrawal of chronic exogenous steroids (#1 overall), pituitary adenoma/apoplexy, Sheehan syndrome | Fulminant Neisseria meningitidis septicemia (endotoxin lipooligosaccharide) → DIC & bilateral hemorrhagic adrenal necrosis | Chromaffin cell catecholamine-secreting tumor of adrenal medulla (90%) or sympathetic ganglia (10% extra-adrenal paraganglioma) |
| ACTH & Skin Pigmentation | Markedly ELEVATED ACTH → excessive POMC cleavage into α-MSH → bronze hyperpigmentation of palmar creases, buccal mucosa, and scars | LOW or inappropriately normal ACTH → NO hyperpigmentation (skin is pale) | Acute catastrophic failure before chronic hyperpigmentation develops; diffuse petechial / purpuric rash (purpura fulminans) | Normal ACTH; episodic pallor, flushing, and drenching diaphoresis during catecholamine paroxysms |
| Aldosterone, Renin & Electrolytes | LOW Aldosterone, HIGH Renin → severe volume depletion, salt craving, hyponatremia, HYPERKALEMIA, and non-anion gap metabolic acidosis (Type 4 RTA) | NORMAL Aldosterone & Renin (RAAS intact!) → NORMAL potassium, euvolemic hyponatremia (cortisol loss disinhibits ADH), hypoglycemia | Profound refractory hypotensive shock, hyponatremia, hyperkalemia, hypoglycemia, and consumptive coagulopathy | Severe paroxysmal or sustained hypertension, orthostatic hypotension (from contracted plasma volume), hyperglycemia |
| Diagnostic Gold Standard | High-dose (250 μg) Cosyntropin (ACTH) stimulation test: cortisol fails to rise > 18–20 μg/dL at 30–60 min + high baseline ACTH | Morning cortisol < 3 μg/dL + low ACTH; prolonged cosyntropin test or insulin tolerance test; pituitary MRI | Clinical emergency diagnosis in meningococcemia; CT abdomen shows bilateral adrenal hemorrhage | Screen: Plasma free fractionated metanephrines or 24-hr urinary fractionated metanephrines & catecholamines → then CT/MRI abdomen (± 123I-MIBG scan) |
| Targeted Pharmacotherapy | Chronic: Hydrocortisone (glucocorticoid) + Fludrocortisone (mineralocorticoid). Crisis: IV Normal Saline + IV Hydrocortisone 100 mg q8h | Hydrocortisone ONLY (no fludrocortisone needed because aldosterone is preserved!) | Immediate IV Ceftriaxone + stress-dose IV Hydrocortisone + aggressive crystalloid/vasopressor resuscitation | Pre-op sequence: 1. Irreversible Alpha-1/2 blocker (Phenoxybenzamine) or Doxazosin + high-salt/fluid diet for 10–14 days → 2. Beta-blocker (Propranolol) → 3. Laparoscopic Adrenalectomy |
Cosyntropin Stimulation Test & Why Dexamethasone Is Used When Testing Is Pending
The Cosyntropin (synthetic ACTH1–24) stimulation test measures serum cortisol at baseline, 30 minutes, and 60 minutes after IV injection of 250 μg cosyntropin; a normal adrenal cortex responds with a peak cortisol ≥ 18–20 μg/dL. In acute adrenal crisis (hypotensive shock refractory to fluids and vasopressors, fever, abdominal pain, vomiting, hyponatremia, hyperkalemia), treatment must NEVER be delayed to perform a cosyntropin stimulation test. If the diagnosis of adrenal insufficiency has not yet been biochemically established, administering IV Dexamethasone (4 mg IV) plus normal saline provides immediate life-saving glucocorticoid activity without cross-reacting in the serum cortisol immunoassay, allowing the cosyntropin stimulation test to be performed simultaneously. If primary AI is already known, IV Hydrocortisone (100 mg IV bolus, then 200 mg/24h) is preferred because high-dose hydrocortisone provides both glucocorticoid and mineralocorticoid activity.
Pheochromocytoma: The Rule of 10s, Syndromic Associations & Pre-Op Alpha-Blockade
Pheochromocytomas arise from neural crest-derived chromaffin cells of the adrenal medulla and present with the classic 5 Ps: Pressure (paroxysmal hypertension), Pain (headache/chest pain), Perspiration (diaphoresis), Palpitations (tachycardia), and Pallor. Historically described by the Rule of 10s: 10% extra-adrenal (paragangliomas, classically at the organ of Zuckerkandl at the inferior mesenteric artery bifurcation), 10% bilateral, 10% malignant (defined ONLY by local invasion or distant metastasis, NOT by histologic mitotic rate or capsular invasion!), 10% pediatric, and 10% calcified (though ~25–30% are hereditary). Hereditary syndromes that mandate pheochromocytoma screening include MEN 2A and MEN 2B (RET), von Hippel-Lindau disease (VHL), Neurofibromatosis type 1 (NF1), and Succinate Dehydrogenase (SDHB/SDHD) familial paraganglioma syndromes. Always obtain biochemical confirmation (plasma free metanephrines or 24-hr urine metanephrines) BEFORE ordering an abdominal CT/MRI, and NEVER biopsy an adrenal mass without ruling out pheochromocytoma first!
Primary Hyperaldosteronism (Conn Syndrome) & The Aldosterone-to-Renin Ratio
Any patient presenting with treatment-resistant hypertension (uncontrolled on ≥ 3 antihypertensives), hypertension with spontaneous or diuretic-induced hypokalemia, metabolic alkalosis, and mild hypernatremia (~145 mEq/L due to aldosterone escape mediated by ANP/BNP) must be screened for Primary Hyperaldosteronism (caused by unilateral adrenal adenoma [Conn syndrome] or bilateral idiopathic adrenal hyperplasia). Because autonomous aldosterone secretion expands intravascular volume, juxtaglomerular renin secretion is suppressed: the initial screening test is the morning plasma Aldosterone-to-Renin Ratio (ARR > 20 with plasma aldosterone > 15 ng/dL), confirmed by a sodium suppression test, and localized via adrenal CT and adrenal venous sampling. Unilateral adenomas are cured by laparoscopic adrenalectomy; bilateral hyperplasia is treated with mineralocorticoid receptor antagonists (Spironolactone or Eplerenone, which avoids spironolactone's anti-androgenic gynecomastia).
COMLEX / OMM Integration
NBOME High-Yield Correlate
Endocrine Autonomics, Chapman Reflexes & Myofascial Considerations
- Thyroid & Parathyroid Autonomic Innervation: Sympathetic preganglionic fibers for the thyroid and parathyroid glands arise from T1–T4, ascend the sympathetic chain, and synapse in the superior, middle, and inferior cervical sympathetic ganglia. Postganglionic fibers regulate thyroid vascularity and follicular hormone secretion. Parasympathetic innervation is supplied by the vagus nerve (CN X) via the superior and recurrent laryngeal nerves. Hyperthyroidism and thyroid storm produce prominent paraspinal tissue texture abnormalities and ropy hypertonicity across C2–C7 and T1–T4.
- Adrenal Gland Autonomic Innervation: Unlike other viscera, the adrenal medulla consists of modified postganglionic sympathetic chromaffin cells innervated directly by preganglionic sympathetic fibers from T10–T11 via the lesser splanchnic nerve (releasing acetylcholine onto nicotinic receptors to stimulate epinephrine/norepinephrine surge). The adrenal cortex is regulated humorally by ACTH and angiotensin II, but adrenal vascular tone maps to T10–T11.
- Chapman Reflexes & OMT Contraindications: The anterior Chapman reflex for the thyroid is located at the second intercostal space adjacent to the sternum (posterior point at the T2 transverse process). The anterior Chapman reflex for the adrenal glands is located 2 to 2.5 inches superior and 1 inch lateral to the umbilicus (posterior point in the intertransverse space between T11 and T12). Crucial Contraindication: Direct cervical myofascial manipulation over an enlarged hypervascular Graves goiter or deep abdominal palpation over a suspected pheochromocytoma is strictly contraindicated, as mechanical compression can trigger massive thyroid hormone or catecholamine release, precipitating fatal thyroid storm or hypertensive crisis!
Board Traps & Common Distractors
- Trap: Administering Potassium Iodide (Lugol solution or SSKI) BEFORE Propylthiouracil (PTU) in thyroid storm. Iodine must be delayed at least 1 hour AFTER PTU has blocked thyroid peroxidase; giving iodine first provides substrate for massive new thyroid hormone synthesis (Jod-Basedow phenomenon)!
- Trap: Administering a beta-blocker (propranolol, labetalol) BEFORE adequate alpha-1 adrenergic blockade (phenoxybenzamine or doxazosin) in a patient with Pheochromocytoma. Blocking vasodilatory skeletal muscle beta-2 receptors leaves alpha-1 vasoconstriction completely unopposed, precipitating fatal hypertensive crisis and pulmonary edema.
- Trap: Giving IV Levothyroxine alone to a patient in Myxedema Coma without concurrent stress-dose IV Hydrocortisone (100 mg IV q8h). Restoring metabolic rate rapidly clears residual serum cortisol, precipitating fatal adrenal crisis if the patient has concomitant autoimmune adrenal insufficiency (Schmidt syndrome) or panhypopituitarism.
- Trap: Performing a Fine-Needle Aspiration (FNA) biopsy on a hyperfunctioning ('hot') thyroid nodule when TSH is suppressed. Hot nodules on radioactive iodine uptake (RAIU) scan are almost never malignant (< 1%) and are treated medically or with radioiodine ablation, not FNA.
- Trap: Prescribing Methimazole during the first trimester of pregnancy. Methimazole causes aplasia cutis congenita and choanal/esophageal atresia; use Propylthiouracil (PTU) during the first trimester, then switch to Methimazole in the second/third trimesters to avoid PTU-induced fulminant hepatotoxicity.
- Trap: Using Etomidate for rapid sequence intubation in a patient with septic shock or suspected adrenal insufficiency. Etomidate directly inhibits adrenal 11β-hydroxylase, acutely suppressing endogenous cortisol synthesis.
- Trap: Failing to check a baseline WBC count with differential in a patient on PTU or Methimazole who develops a sore throat and fever. Thionamides cause idiosyncratic agranulocytosis (ANC < 500/μL); immediately discontinue the drug—never wait for outpatient follow-up!
Previous Chapter
•
Vol 2: Clinical Ch. 10
Obstetric Emergencies & Hypertensive Disorders of Pregnancy
Vol 2: Clinical Ch. 12
•
Next Chapter
Cirrhosis, Portal Hypertension & Hepatic Encephalopathy
Table of Contents (105 Chapters)
Volume 2: Organ System Clinical Pathology • Chapter 11 of 60